InsiderClue
Insiders · Profile

Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN. at Celldex Therapeutics. Filing since 10 Jun 2020. CIK 0001709113

Company
Date
Role
Action
Shares
Amount
Of holding
CLDX Celldex Therapeutics, Inc.
30 May 2024
SVP OF CORP AFFAIRS & ADMIN.
Sold at will
20,853
$703.33K
91.8%
CLDX Celldex Therapeutics, Inc.
18 Aug 2022
SVP OF CORP AFFAIRS & ADMIN.
Sold, plan not stated
1,355
$49.29K
51.3%
CLDX Celldex Therapeutics, Inc.
17 Aug 2022
SVP OF CORP AFFAIRS & ADMIN.
Sold, plan not stated
31,312
$1.15M
96.1%
CLDX Celldex Therapeutics, Inc.
8 Dec 2021
SVP of Corp Affairs & Admin.
Sold, plan not stated
7,323
$292.92K
94.7%
CLDX Celldex Therapeutics, Inc.
1 Nov 2021
SVP of Corp Affairs & Admin.
Sold, plan not stated
7,323
$316.80K
94.7%
CLDX Celldex Therapeutics, Inc.
10 Jun 2020
SVP of Corp Affairs & Admin.
Bought
1,050
$5.07K
331%
6 decisions on file.